HGNC Family | C2 domain containing |
Name | phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha |
Description | Phosphatidylinositol 3-kinase is composed of an 85 kDa regulatory subunit and a 110 kDa catalytic subunit. The protein encoded by this gene represents the catalytic subunit, which uses ATP to phosphorylate PtdIns, PtdIns4P and PtdIns(4,5)P2. This gene has been found to be oncogenic and has been implicated in cervical cancers. A pseudogene of this gene has been defined on chromosome 22. [provided by RefSeq, Apr 2016] |
Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nPIK3CA encodes the p110α catalytic subunit of class IA phosphoinositide 3‐kinase, a critical enzyme that phosphorylates membrane phosphatidylinositols to generate second messengers and thereby activate downstream AKT/mTOR signaling. Activating “hotspot” mutations—most notably within the helical (e.g. E542K, E545K) and kinase (e.g. H1047R) domains—enhance p110α’s lipid kinase activity. This aberrant activation promotes cell survival, proliferation, growth factor independence, and oncogenic transformation in diverse contexts. Detailed biochemical analyses, structural studies, and experimental models (including gene targeting in cell culture and mouse models) have demonstrated that these mutations disrupt inhibitory interactions with regulatory subunits and potentiate constitutive signal transduction, leading to enhanced phosphorylation of AKT and downstream effectors that regulate cell cycle and protein synthesis."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "31"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nClinically, mutant PIK3CA not only serves as a prognostic and predictive biomarker but also informs therapeutic strategies. Its presence has been linked to resistance to certain targeted agents—such as anti‐EGFR monoclonal antibodies in colorectal cancer and trastuzumab in breast cancer—while simultaneously identifying tumors that may be more responsive to PI3K, mTOR, or dual PI3K/mTOR inhibitors. In addition, its interaction with other pathway components (for example, the frequent mutual exclusivity with PTEN loss) highlights divergent molecular routes of tumor evolution. Beyond oncogenesis, post‐zygotic activating mutations in PIK3CA have been implicated in a spectrum of overgrowth and vascular malformation disorders, emphasizing the enzyme’s central role in regulating normal as well as aberrant cellular growth."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "32", "end_ref": "43"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nThese cumulative insights have spurred the development of next‐generation therapies, including isoform–selective inhibitors and combination regimens (for instance, with CDK4/6 or MEK inhibitors) designed to overcome intrinsic or adaptive resistance. Further structural and functional characterization of PIK3CA mutations continues to inform precision medicine approaches—not only in oncology but also in congenital overgrowth syndromes—by pinpointing critical vulnerabilities within the PI3K/AKT/mTOR axis."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "44"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "C L Carpenter, B C Duckworth, K R Auger, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Purification and characterization of phosphoinositide 3-kinase from rat liver."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (1990)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "2174051"}], "href": "https://pubmed.ncbi.nlm.nih.gov/2174051"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Kurtis E Bachman, Pedram Argani, Yardena Samuels, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The PIK3CA gene is mutated with high frequency in human breast cancers."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Biol Ther (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4161/cbt.3.8.994"}], "href": "https://doi.org/10.4161/cbt.3.8.994"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15254419"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15254419"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Daniel K Broderick, Chunhui Di, Timothy J Parrett, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mutations of PIK3CA in anaplastic oligodendrogliomas, high-grade astrocytomas, and medulloblastomas."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-04-1170"}], "href": "https://doi.org/10.1158/0008-5472.CAN-04-1170"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15289301"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15289301"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Yardena Samuels, Victor E Velculescu "}, {"type": "b", "children": [{"type": "t", "text": "Oncogenic mutations of PIK3CA in human cancers."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Cycle (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4161/cc.3.10.1164"}], "href": "https://doi.org/10.4161/cc.3.10.1164"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15467468"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15467468"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Sohye Kang, Andreas G Bader, Peter K Vogt "}, {"type": "b", "children": [{"type": "t", "text": "Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.0408864102"}], "href": "https://doi.org/10.1073/pnas.0408864102"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15647370"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15647370"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Lao H Saal, Karolina Holm, Matthew Maurer, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472-CAN-04-3913"}], "href": "https://doi.org/10.1158/0008-5472-CAN-04-3913"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15805248"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15805248"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Douglas A Levine, Faina Bogomolniy, Cindy J Yee, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Frequent mutation of the PIK3CA gene in ovarian and breast cancers."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Cancer Res (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1078-0432.CCR-04-2142"}], "href": "https://doi.org/10.1158/1078-0432.CCR-04-2142"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15837735"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15837735"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Tsuneo Ikenoue, Fumihiko Kanai, Yohko Hikiba, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Functional analysis of PIK3CA gene mutations in human colorectal cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-04-4114"}], "href": "https://doi.org/10.1158/0008-5472.CAN-04-4114"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15930273"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15930273"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Yardena Samuels, Luis A Diaz, Oleg Schmidt-Kittler, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mutant PIK3CA promotes cell growth and invasion of human cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Cell (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ccr.2005.05.014"}], "href": "https://doi.org/10.1016/j.ccr.2005.05.014"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15950905"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15950905"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Sérgia Velho, Carla Oliveira, Ana Ferreira, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The prevalence of PIK3CA mutations in gastric and colon cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur J Cancer (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ejca.2005.04.022"}], "href": "https://doi.org/10.1016/j.ejca.2005.04.022"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15994075"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15994075"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Jean J Zhao, Zhenning Liu, Li Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The oncogenic properties of mutant p110alpha and p110beta phosphatidylinositol 3-kinases in human mammary epithelial cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.0508988102"}], "href": "https://doi.org/10.1073/pnas.0508988102"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16339315"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16339315"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Andreas G Bader, Sohye Kang, Li Zhao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Oncogenic PI3K deregulates transcription and translation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Rev Cancer (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nrc1753"}], "href": "https://doi.org/10.1038/nrc1753"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16341083"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16341083"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Astrid Lièvre, Jean-Baptiste Bachet, Delphine Le Corre, et al. "}, {"type": "b", "children": [{"type": "t", "text": "KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-06-0191"}], "href": "https://doi.org/10.1158/0008-5472.CAN-06-0191"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16618717"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16618717"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Peng Hou, Dingxie Liu, Yuan Shan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genetic alterations and their relationship in the phosphatidylinositol 3-kinase/Akt pathway in thyroid cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Cancer Res (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1078-0432.CCR-06-1125"}], "href": "https://doi.org/10.1158/1078-0432.CCR-06-1125"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17317825"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17317825"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Marco Gymnopoulos, Marc-André Elsliger, Peter K Vogt "}, {"type": "b", "children": [{"type": "t", "text": "Rare cancer-specific mutations in PIK3CA show gain of function."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.0701005104"}], "href": "https://doi.org/10.1073/pnas.0701005104"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17376864"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17376864"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Katrien Berns, Hugo M Horlings, Bryan T Hennessy, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Cell (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ccr.2007.08.030"}], "href": "https://doi.org/10.1016/j.ccr.2007.08.030"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17936563"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17936563"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Chuan-Hsiang Huang, Diana Mandelker, Oleg Schmidt-Kittler, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The structure of a human p110alpha/p85alpha complex elucidates the effects of oncogenic PI3Kalpha mutations."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Science (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1126/science.1150799"}], "href": "https://doi.org/10.1126/science.1150799"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18079394"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18079394"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Mariona Graupera, Julie Guillermet-Guibert, Lazaros C Foukas, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Angiogenesis selectively requires the p110alpha isoform of PI3K to control endothelial cell migration."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nature (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nature06892"}], "href": "https://doi.org/10.1038/nature06892"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18449193"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18449193"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Katherine Stemke-Hale, Ana Maria Gonzalez-Angulo, Ana Lluch, et al. "}, {"type": "b", "children": [{"type": "t", "text": "An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-07-6854"}], "href": "https://doi.org/10.1158/0008-5472.CAN-07-6854"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18676830"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18676830"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "F Perrone, A Lampis, M Orsenigo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PI3KCA/PTEN deregulation contributes to impaired responses to cetuximab in metastatic colorectal cancer patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Ann Oncol (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/annonc/mdn541"}], "href": "https://doi.org/10.1093/annonc/mdn541"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18669866"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18669866"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Hiromasa Yamamoto, Hisayuki Shigematsu, Masaharu Nomura, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PIK3CA mutations and copy number gains in human lung cancers."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-07-5084"}], "href": "https://doi.org/10.1158/0008-5472.CAN-07-5084"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18757405"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18757405"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "L Zhao, P K Vogt "}, {"type": "b", "children": [{"type": "t", "text": "Class I PI3K in oncogenic cellular transformation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2008.244"}], "href": "https://doi.org/10.1038/onc.2008.244"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18794883"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18794883"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Jeffrey A Engelman, Liang Chen, Xiaohong Tan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Med (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nm.1890"}], "href": "https://doi.org/10.1038/nm.1890"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19029981"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19029981"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Andrea Sartore-Bianchi, Miriam Martini, Francesca Molinari, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PIK3CA mutations in colorectal cancer are associated with clinical resistance to EGFR-targeted monoclonal antibodies."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-08-2466"}], "href": "https://doi.org/10.1158/0008-5472.CAN-08-2466"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19223544"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19223544"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Kuan-Ting Kuo, Tsui-Lien Mao, Siân Jones, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Frequent activating mutations of PIK3CA in ovarian clear cell carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Pathol (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2353/ajpath.2009.081000"}], "href": "https://doi.org/10.2353/ajpath.2009.081000"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19349352"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19349352"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Julio C Ricarte-Filho, Mabel Ryder, Dhananjay A Chitale, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mutational profile of advanced primary and metastatic radioactive iodine-refractory thyroid cancers reveals distinct pathogenetic roles for BRAF, PIK3CA, and AKT1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-09-0727"}], "href": "https://doi.org/10.1158/0008-5472.CAN-09-0727"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19487299"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19487299"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Krishna M Vasudevan, David A Barbie, Michael A Davies, et al. "}, {"type": "b", "children": [{"type": "t", "text": "AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Cell (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ccr.2009.04.012"}], "href": "https://doi.org/10.1016/j.ccr.2009.04.012"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19573809"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19573809"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Sherene Loi, Benjamin Haibe-Kains, Samira Majjaj, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PIK3CA mutations associated with gene signature of low mTORC1 signaling and better outcomes in estrogen receptor-positive breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.0907011107"}], "href": "https://doi.org/10.1073/pnas.0907011107"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20479250"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20479250"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Michael Rivera, Julio Ricarte-Filho, Jeff Knauf, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Molecular genotyping of papillary thyroid carcinoma follicular variant according to its histological subtypes (encapsulated vs infiltrative) reveals distinct BRAF and RAS mutation patterns."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mod Pathol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/modpathol.2010.112"}], "href": "https://doi.org/10.1038/modpathol.2010.112"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20526288"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20526288"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Wendy De Roock, Bart Claes, David Bernasconi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Lancet Oncol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/S1470-2045(10)70130-3"}], "href": "https://doi.org/10.1016/S1470-2045(10"}, {"type": "t", "text": "70130-3) PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20619739"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20619739"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Xinbo Zhang, Naimei Tang, Timothy J Hadden, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Akt, FoxO and regulation of apoptosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochim Biophys Acta (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbamcr.2011.03.010"}], "href": "https://doi.org/10.1016/j.bbamcr.2011.03.010"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21440011"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21440011"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Filip Janku, Jennifer J Wheler, Shannon N Westin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PI3K/AKT/mTOR inhibitors in patients with breast and gynecologic malignancies harboring PIK3CA mutations."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Oncol (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1200/JCO.2011.36.1196"}], "href": "https://doi.org/10.1200/JCO.2011.36.1196"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22271473"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22271473"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Kyle C Kurek, Valerie L Luks, Ugur M Ayturk, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Somatic mosaic activating mutations in PIK3CA cause CLOVES syndrome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Hum Genet (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ajhg.2012.05.006"}], "href": "https://doi.org/10.1016/j.ajhg.2012.05.006"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22658544"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22658544"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Jeong Ho Lee, My Huynh, Jennifer L Silhavy, et al. "}, {"type": "b", "children": [{"type": "t", "text": "De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Genet (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ng.2329"}], "href": "https://doi.org/10.1038/ng.2329"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22729223"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22729223"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Jean-Baptiste Rivière, Ghayda M Mirzaa, Brian J O'Roak, et al. "}, {"type": "b", "children": [{"type": "t", "text": "De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Genet (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ng.2331"}], "href": "https://doi.org/10.1038/ng.2331"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22729224"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22729224"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Xiaoyun Liao, Paul Lochhead, Reiko Nishihara, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "N Engl J Med (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1056/NEJMoa1207756"}], "href": "https://doi.org/10.1056/NEJMoa1207756"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23094721"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23094721"}]}, {"type": "r", "ref": 37, "children": [{"type": "t", "text": "Stefan Eser, Nina Reiff, Marlena Messer, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Selective requirement of PI3K/PDK1 signaling for Kras oncogene-driven pancreatic cell plasticity and cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Cell (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ccr.2013.01.023"}], "href": "https://doi.org/10.1016/j.ccr.2013.01.023"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23453624"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23453624"}]}, {"type": "r", "ref": 38, "children": [{"type": "t", "text": "Christina Therkildsen, Troels K Bergmann, Tine Henrichsen-Schnack, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The predictive value of KRAS, NRAS, BRAF, PIK3CA and PTEN for anti-EGFR treatment in metastatic colorectal cancer: A systematic review and meta-analysis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Acta Oncol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3109/0284186X.2014.895036"}], "href": "https://doi.org/10.3109/0284186X.2014.895036"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24666267"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24666267"}]}, {"type": "r", "ref": 39, "children": [{"type": "t", "text": "Stephen Henderson, Ankur Chakravarthy, Xiaoping Su, et al. "}, {"type": "b", "children": [{"type": "t", "text": "APOBEC-mediated cytosine deamination links PIK3CA helical domain mutations to human papillomavirus-driven tumor development."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Rep (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.celrep.2014.05.012"}], "href": "https://doi.org/10.1016/j.celrep.2014.05.012"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24910434"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24910434"}]}, {"type": "r", "ref": 40, "children": [{"type": "t", "text": "Sadhna R Vora, Dejan Juric, Nayoon Kim, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CDK 4/6 inhibitors sensitize PIK3CA mutant breast cancer to PI3K inhibitors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Cell (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ccr.2014.05.020"}], "href": "https://doi.org/10.1016/j.ccr.2014.05.020"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25002028"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25002028"}]}, {"type": "r", "ref": 41, "children": [{"type": "t", "text": "Valerie L Luks, Nolan Kamitaki, Matthew P Vivero, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Lymphatic and other vascular malformative/overgrowth disorders are caused by somatic mutations in PIK3CA."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Pediatr (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jpeds.2014.12.069"}], "href": "https://doi.org/10.1016/j.jpeds.2014.12.069"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25681199"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25681199"}]}, {"type": "r", "ref": 42, "children": [{"type": "t", "text": "Massimo Cristofanilli, Nicholas C Turner, Igor Bondarenko, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Lancet Oncol (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/S1470-2045(15)00613-0"}], "href": "https://doi.org/10.1016/S1470-2045(15"}, {"type": "t", "text": "00613-0) PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26947331"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26947331"}]}, {"type": "r", "ref": 43, "children": [{"type": "t", "text": "Patricia Mucci LoRusso "}, {"type": "b", "children": [{"type": "t", "text": "Inhibition of the PI3K/AKT/mTOR Pathway in Solid Tumors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Oncol (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1200/JCO.2014.59.0018"}], "href": "https://doi.org/10.1200/JCO.2014.59.0018"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27621407"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27621407"}]}, {"type": "r", "ref": 44, "children": [{"type": "t", "text": "Yi-Zhou Jiang, Ding Ma, Chen Suo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Cell (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ccell.2019.02.001"}], "href": "https://doi.org/10.1016/j.ccell.2019.02.001"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30853353"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30853353"}]}]}]}
|
Synonyms | MCAP, MCMTC, PI3K-alpha, PI3K, CWS5, P110-ALPHA, CLAPO, CLOVE |
Proteins | PK3CA_HUMAN |
NCBI Gene ID | 5290 |
API | |
Download Associations | |
Predicted Functions |
![]() |
Co-expressed Genes |
![]() |
Expression in Tissues and Cell Lines |
![]() |
PIK3CA has 20,240 functional associations with biological entities spanning 8 categories (molecular profile, organism, functional term, phrase or reference, disease, phenotype or trait, chemical, structural feature, cell line, cell type or tissue, gene, protein or microRNA) extracted from 131 datasets.
Click the + buttons to view associations for PIK3CA from the datasets below.
If available, associations are ranked by standardized value
Dataset | Summary | |
---|---|---|
Achilles Cell Line Gene Essentiality Profiles | cell lines with fitness changed by PIK3CA gene knockdown relative to other cell lines from the Achilles Cell Line Gene Essentiality Profiles dataset. | |
Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of PIK3CA gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles | tissues with high or low expression of PIK3CA gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset. | |
Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of PIK3CA gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq | tissue samples with high or low expression of PIK3CA gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset. | |
Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of PIK3CA gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
Biocarta Pathways | pathways involving PIK3CA protein from the Biocarta Pathways dataset. | |
BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of PIK3CA gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of PIK3CA gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of PIK3CA gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of PIK3CA gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of PIK3CA gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
CCLE Cell Line Gene Mutation Profiles | cell lines with PIK3CA gene mutations from the CCLE Cell Line Gene Mutation Profiles dataset. | |
CCLE Cell Line Proteomics | Cell lines associated with PIK3CA protein from the CCLE Cell Line Proteomics dataset. | |
CellMarker Gene-Cell Type Associations | cell types associated with PIK3CA gene from the CellMarker Gene-Cell Type Associations dataset. | |
ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of PIK3CA gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
ChEA Transcription Factor Targets | transcription factors binding the promoter of PIK3CA gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of PIK3CA gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
ClinVar Gene-Phenotype Associations | phenotypes associated with PIK3CA gene from the curated ClinVar Gene-Phenotype Associations dataset. | |
CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of PIK3CA gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing PIK3CA protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing PIK3CA protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
COMPARTMENTS Experimental Protein Localization Evidence Scores | cellular components containing PIK3CA protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores dataset. | |
COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 | cellular components containing PIK3CA protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 dataset. | |
COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with PIK3CA protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with PIK3CA protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
CORUM Protein Complexes | protein complexs containing PIK3CA protein from the CORUM Protein Complexes dataset. | |
COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of PIK3CA gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
COSMIC Cell Line Gene Mutation Profiles | cell lines with PIK3CA gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
CTD Gene-Chemical Interactions | chemicals interacting with PIK3CA gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
CTD Gene-Disease Associations | diseases associated with PIK3CA gene/protein from the curated CTD Gene-Disease Associations dataset. | |
DISEASES Curated Gene-Disease Association Evidence Scores | diseases involving PIK3CA gene from the DISEASES Curated Gene-Disease Assocation Evidence Scores dataset. | |
DISEASES Curated Gene-Disease Association Evidence Scores 2025 | diseases involving PIK3CA gene from the DISEASES Curated Gene-Disease Association Evidence Scores 2025 dataset. | |
DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with PIK3CA gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with PIK3CA gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
DisGeNET Gene-Disease Associations | diseases associated with PIK3CA gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
DisGeNET Gene-Phenotype Associations | phenotypes associated with PIK3CA gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
DrugBank Drug Targets | interacting drugs for PIK3CA protein from the curated DrugBank Drug Targets dataset. | |
ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at PIK3CA gene from the ENCODE Histone Modification Site Profiles dataset. | |
ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of PIK3CA gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
ENCODE Transcription Factor Targets | transcription factors binding the promoter of PIK3CA gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing PIK3CA from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
GAD Gene-Disease Associations | diseases associated with PIK3CA gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
GAD High Level Gene-Disease Associations | diseases associated with PIK3CA gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset. | |
GDSC Cell Line Gene Expression Profiles | cell lines with high or low expression of PIK3CA gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset. | |
GeneRIF Biological Term Annotations | biological terms co-occuring with PIK3CA gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing PIK3CA from the GeneSigDB Published Gene Signatures dataset. | |
GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of PIK3CA gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of PIK3CA gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of PIK3CA gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of PIK3CA gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of PIK3CA gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of PIK3CA gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
GO Biological Process Annotations 2015 | biological processes involving PIK3CA gene from the curated GO Biological Process Annotations 2015 dataset. | |
GO Biological Process Annotations 2023 | biological processes involving PIK3CA gene from the curated GO Biological Process Annotations 2023 dataset. | |
GO Biological Process Annotations 2025 | biological processes involving PIK3CA gene from the curated GO Biological Process Annotations2025 dataset. | |
GO Cellular Component Annotations 2015 | cellular components containing PIK3CA protein from the curated GO Cellular Component Annotations 2015 dataset. | |
GO Cellular Component Annotations 2023 | cellular components containing PIK3CA protein from the curated GO Cellular Component Annotations 2023 dataset. | |
GO Cellular Component Annotations 2025 | cellular components containing PIK3CA protein from the curated GO Cellular Component Annotations 2025 dataset. | |
GO Molecular Function Annotations 2015 | molecular functions performed by PIK3CA gene from the curated GO Molecular Function Annotations 2015 dataset. | |
GO Molecular Function Annotations 2023 | molecular functions performed by PIK3CA gene from the curated GO Molecular Function Annotations 2023 dataset. | |
GO Molecular Function Annotations 2025 | molecular functions performed by PIK3CA gene from the curated GO Molecular Function Annotations 2025 dataset. | |
GTEx Tissue Gene Expression Profiles | tissues with high or low expression of PIK3CA gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of PIK3CA gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of PIK3CA gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
GWASdb SNP-Disease Associations | diseases associated with PIK3CA gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset. | |
GWASdb SNP-Phenotype Associations | phenotypes associated with PIK3CA gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset. | |
Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of PIK3CA gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
HMDB Metabolites of Enzymes | interacting metabolites for PIK3CA protein from the curated HMDB Metabolites of Enzymes dataset. | |
HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of PIK3CA gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
HPA Tissue Gene Expression Profiles | tissues with high or low expression of PIK3CA gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
HPA Tissue Protein Expression Profiles | tissues with high or low expression of PIK3CA protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset. | |
HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of PIK3CA gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
HPO Gene-Disease Associations | phenotypes associated with PIK3CA gene by mapping known disease genes to disease phenotypes from the HPO Gene-Disease Associations dataset. | |
Hub Proteins Protein-Protein Interactions | interacting hub proteins for PIK3CA from the curated Hub Proteins Protein-Protein Interactions dataset. | |
HuGE Navigator Gene-Phenotype Associations | phenotypes associated with PIK3CA gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
HumanCyc Pathways | pathways involving PIK3CA protein from the HumanCyc Pathways dataset. | |
InterPro Predicted Protein Domain Annotations | protein domains predicted for PIK3CA protein from the InterPro Predicted Protein Domain Annotations dataset. | |
JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of PIK3CA gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
KEA Substrates of Kinases | kinases that phosphorylate PIK3CA protein from the curated KEA Substrates of Kinases dataset. | |
KEGG Pathways | pathways involving PIK3CA protein from the KEGG Pathways dataset. | |
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of PIK3CA gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of PIK3CA gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles | cell lines with PIK3CA gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset. | |
KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of PIK3CA gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
LINCS KinomeScan Kinase Inhibitor Targets | small molecules inhibiting PIK3CA kinase from the KinomeScan Kinase Inhibitor Targets dataset. | |
LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of PIK3CA gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
LINCS L1000 CMAP CRISPR Knockout Consensus Signatures | gene perturbations changing expression of PIK3CA gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset. | |
LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of PIK3CA gene from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain PIK3CA protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by PIK3CA gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
MiRTarBase microRNA Targets | microRNAs targeting PIK3CA gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset. | |
MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of PIK3CA gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
MoTrPAC Rat Endurance Exercise Training | tissue samples with high or low expression of PIK3CA gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset. | |
MPO Gene-Phenotype Associations | phenotypes of transgenic mice caused by PIK3CA gene mutations from the MPO Gene-Phenotype Associations dataset. | |
MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations | gene perturbations changing expression of PIK3CA gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset. | |
MW Enzyme Metabolite Associations | interacting metabolites for PIK3CA protein from the MW Gene Metabolite Associations dataset. | |
NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of PIK3CA gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
NURSA Protein Complexes | protein complexs containing PIK3CA protein recovered by IP-MS from the NURSA Protein Complexes dataset. | |
NURSA Protein-Protein Interactions | interacting proteins for PIK3CA from the NURSA Protein-Protein Interactions dataset. | |
OMIM Gene-Disease Associations | phenotypes associated with PIK3CA gene from the curated OMIM Gene-Disease Associations dataset. | |
PANTHER Pathways | pathways involving PIK3CA protein from the PANTHER Pathways dataset. | |
Pathway Commons Protein-Protein Interactions | interacting proteins for PIK3CA from the Pathway Commons Protein-Protein Interactions dataset. | |
PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of PIK3CA gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of PIK3CA gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
PFOCR Pathway Figure Associations 2023 | pathways involving PIK3CA protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
PFOCR Pathway Figure Associations 2024 | pathways involving PIK3CA protein from the Wikipathways PFOCR 2024 dataset. | |
PID Pathways | pathways involving PIK3CA protein from the PID Pathways dataset. | |
Reactome Pathways 2014 | pathways involving PIK3CA protein from the Reactome Pathways dataset. | |
Reactome Pathways 2024 | pathways involving PIK3CA protein from the Reactome Pathways 2024 dataset. | |
Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of PIK3CA gene from the Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of PIK3CA gene from the Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures dataset. | |
Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of PIK3CA gene from the Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of PIK3CA gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |
Roadmap Epigenomics Cell and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of PIK3CA gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset. | |
Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at PIK3CA gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of PIK3CA gene from the RummaGEO Drug Perturbation Signatures dataset. | |
RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of PIK3CA gene from the RummaGEO Gene Perturbation Signatures dataset. | |
SILAC Phosphoproteomics Signatures of Differentially Phosphorylated Proteins for Gene Perturbations | gene perturbations changing phosphorylation of PIK3CA protein from the SILAC Phosphoproteomics Signatures of Differentially Phosphorylated Proteins for Gene Perturbations dataset. | |
SILAC Phosphoproteomics Signatures of Differentially Phosphorylated Proteins for Protein Ligands | ligand (protein) perturbations changing phosphorylation of PIK3CA protein from the SILAC Phosphoproteomics Signatures of Differentially Phosphorylated Proteins for Protein Ligands dataset. | |
TargetScan Predicted Conserved microRNA Targets | microRNAs regulating expression of PIK3CA gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset. | |
TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of PIK3CA gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of PIK3CA gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of PIK3CA protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of PIK3CA protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of PIK3CA protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of PIK3CA protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with PIK3CA protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with PIK3CA protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
WikiPathways Pathways 2014 | pathways involving PIK3CA protein from the Wikipathways Pathways 2014 dataset. | |
WikiPathways Pathways 2024 | pathways involving PIK3CA protein from the WikiPathways Pathways 2024 dataset. | |